Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 5:47 AM ET

Healthcare Equipment and Supplies

Company Overview of ACell, Inc.

Company Overview

ACell, Inc. engages in the development and commercialization of extracellular matrix devices to repair and remodel damaged tissues and organs in a range of surgical procedures for the U.S. and international patents. It offers MatriStem technology, a non-crosslinked, resorbable, and acellular material; MatriStem Wound Care Matrix, a wound care device with regenerative medicine technology; MatriStem Plastic Surgery Matrix, a plastic surgery and wound care device; MatriStem Hernia Matrix, a general surgery device; and Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer that are wound management devices for the management of partial- and full-thickness wounds, including pressure ulcers, ve...

6640 Eli Whitney Drive

Columbia, MD 21046

United States

Founded in 1999

Phone:

410-715-1700

Fax:

410-715-4511

Key Executives for ACell, Inc.

Chief Executive Officer and President
Age: 63
Chief Financial Officer
Age: 67
Vice President of Operations
Senior Vice President and General Counsel
Age: 58
Vice President of Product Development
Compensation as of Fiscal Year 2015.

ACell, Inc. Key Developments

ACell, Inc. Announces Management Changes

ACell, Inc. announced that it has named Patrick (Pat) McBrayer as President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain as Chairman of the Board. McBrayer has more than 20 years of healthcare senior management experience. He currently serves on the Board of Directors of Misonix, Inc. and was President and CEO of AxioMed Spine Corporation until the company was acquired in 2014. McBrayer is on the Board of Directors of Misonix Inc. He has recently advised medical device companies in spine, orthopedics and biotechnology.

ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds

ACell, Inc. announced the introduction of two new wound management devices: Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer. These devices are intended for the management of partial- and full-thickness wounds including pressure ulcers, venous ulcers, diabetic ulcers, tunneled wounds, traumatic wounds, and surgical wounds. Cytal wound matrices allow for prolonged persistence of ACell's proprietary Urinary Bladder Matrix (UBM) in the wound, providing for a robust scaffold for cell infiltration and may reduce need for follow up care. The pre-fenestrated design is highly conformable in irregular wound beds and supports effective fluid management. Cytal will be available in three sizes in both 3- and 6-layer configurations. ACell's wound management portfolio also includes MicroMatrix, MatriStem Wound Matrix, MatriStem Multilayer Wound Matrix, and MatriStem Burn Matrix. ACell also manufactures and distributes a line of surgical devices including various MatriStem Surgical Matrix sheets and MatriStem Pelvic Floor Matrix.

ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus

ACell, Inc. announced the release of MatriStem Surgical Matrix Plus, which is indicated for use in a range of surgical procedures including tissue repair, body wall repair, and hernia repair at the American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting. The product was designed to provide the strength and support needed in abdominal wall procedures, while also offering superior handling. Its reduced preparation time can also increase operating room efficiency, while its optimal and conformability make it suitable for increasingly common minimally invasive procedures. Surgical Matrix Plus will be featured in the ASCRS New Technologies Symposium, a showcase for innovative products. MatriStem Surgical Matrix Plus will be available in four sizes, and is part of the MatriStem Surgical Matrix product family, which includes Surgical Matrix RS, PSM, PSMX.

Similar Private Companies By Industry

Company Name Region
Denver Biomedical, Inc. United States
Imaging Sciences International, Inc. United States
Paragon Vision Sciences, Inc. United States
HEARx West LLC United States
Rehab Designs, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ACell, Inc., please visit www.acell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.